Patients

Five things for pharma marketers to know: Friday, May 26, 2017

Five things for pharma marketers to know: Friday, May 26, 2017

By

FDA presents ideas to tackle drug prices; patients aware of side effects more likely to report them; scientists use Apple's Research Kit for clinical purposes

Apple helps a blind drummer and nonverbal teen thrive in new spots

Apple helps a blind drummer and nonverbal teen thrive in new spots

Siri and accessibility features take center stage in ads for Global Accessibility Awareness Day.

Expert Q&A: Getting patient centricity right

Expert Q&A: Getting patient centricity right

Five sector pros discuss adapting to patient-centricity and how pinpointing patient needs leads to success.

Five things for pharma marketers to know: Thursday, May 18, 2017

Five things for pharma marketers to know: Thursday, May 18, 2017

By

Docs spend little time telling patients about cancer costs; Shire to file hereditary angioedema drug with the FDA by 2018; Philips CEO on access obstacles

Infographic: The battle for medication adherence

Infographic: The battle for medication adherence

Drugmakers and providers alike struggle to find the best tools, words, and technologies that will improve adherence rates among patients with chronic diseases.

Five things for pharma marketers to know: Monday, May 15, 2017

Five things for pharma marketers to know: Monday, May 15, 2017

By

Funding for patient-assistance charities makes up 7% of operating expenses for drugmakers; Avanir ad under fire; Trump to consider Medicare rebates

Day 1 at Health Datapalooza

Day 1 at Health Datapalooza

By

HHS Secretary Tom Price calls for health IT that works for clinicians and better interoperability.

5 of healthcare's hardest nuts to crack

5 of healthcare's hardest nuts to crack

How are pharma, clinical, and startup execs addressing some of the biggest challenges facing their businesses today?

Dr. John Brownstein, Circulation

Dr. John Brownstein, Circulation

Dr. John Brownstein is cofounder of Circulation and chief innovation officer at Boston Children's Hospital.

Jeff Ceitlin, HVH Patient Precision Analytics

Jeff Ceitlin, HVH Patient Precision Analytics

Jeff Ceitlin is CCO of HVH Patient Precision Analytics.

Adrian Aoun, Forward

Adrian Aoun, Forward

Adrian Aoun is the CEO and founder of Forward.

Nothing Will Replace Human Doctors, Not Even Robots

Nothing Will Replace Human Doctors, Not Even Robots

Healthcare is one industry that hangs in this delicate balance, in large part due to the fact that it necessitates a blend of science and empathy.

What doctors have to say about those DTC ads

What doctors have to say about those DTC ads

By

We had SERMO, a social network for physicians, ask about 1,700 physicians what they have to say about the impact of DTC on patient care and choices. Note: It's not pretty.

Five things for pharma marketers to know: Wednesday, March 22, 2017

Five things for pharma marketers to know: Wednesday, March 22, 2017

By

Novartis' heart-failure drug fails in clinical trial; Sanofi, Regeneron file Dupixent patent suit; FDA approves Newron's Xadago for PD

New healthcare bill to negatively affect drugmakers: Moody's

New healthcare bill to negatively affect drugmakers: Moody's

By

Per the credit ratings agency, more uninsured Americans will lead to less demand for healthcare services and treatments.

From SXSW: Learnings for Healthcare Marketers from the NYT and WWE

From SXSW: Learnings for Healthcare Marketers from the NYT and WWE

As we build health solutions, making decisions in office parks and around conference tables, it's easy to lose the individual person through the scale of our work.

Gottlieb Likely to Take On Off-Label, Predictability at the FDA

Gottlieb Likely to Take On Off-Label, Predictability at the FDA

In short, he'll be further along the learning curve than anyone ever tapped for the nation's number-one public health regulatory slot.

Five things for pharma marketers to know: Wednesday, March 15, 2017

Five things for pharma marketers to know: Wednesday, March 15, 2017

By

The FDA considers creating Office of Patient Affairs; Alexion to cut 7% of workforce; FDA committee votes against painkiller's benefits

Klara's Simon Lorenz on breaking away from the physician lifestyle

Klara's Simon Lorenz on breaking away from the physician lifestyle

By

He instead decided to find a way to make a physician's job easier by creating a clinical messaging platform.

Infographic: What's next for the point of care market

Infographic: What's next for the point of care market

About 30% of patients are more likely to fill a prescription after being exposed to healthcare ads at the point of care, according to Kantar Media.

Five things for pharma marketers to know: Monday, February 27, 2017

Five things for pharma marketers to know: Monday, February 27, 2017

By

Pfizer receives subpoena over patient assistance programs; drugmakers raise prices less this January than last; lawmakers have new plan to repeal ACA

Predicting Patient Behavior Improves the Brand Message

Predicting Patient Behavior Improves the Brand Message

Few questions give healthcare marketers more heart palpitations than this one: "How do you know it will work?"

Top 25 rare disease brands, by sales

Top 25 rare disease brands, by sales

Teva Pharmaceutical Industries' Copaxone is by far the top-selling drug, bringing in $3.2 billion in U.S. sales in 2015.

Genentech Should Let Us See Its Herceptin Documentary

Genentech Should Let Us See Its Herceptin Documentary

By

The 2009 documentary offers a wealth of detail. Which is why it makes no sense that Genentech doesn't want you to see the damn thing.

Marketers take a new approach to lung-cancer campaigns, and why that matters

Marketers take a new approach to lung-cancer campaigns, and why that matters

By

Each of the approaches is valid and more ambitious than a great majority of the campaigns that preceded them.

Five things for pharma marketers to know: Tuesday, January 31, 2017

Five things for pharma marketers to know: Tuesday, January 31, 2017

By

Diabetes patients sue drugmakers over price increases; the FTC opens Mylan investigation; Fitbit to ramp up marketing

Giant's Kristina Ellis Highlights 6 Campaigns that Create Empathy

Giant's Kristina Ellis Highlights 6 Campaigns that Create Empathy

Here are six creative campaigns that use creativity to connect with the audience.

For statin-intolerant patients, what's next?

For statin-intolerant patients, what's next?

By

Despite their blockbuster status and distinction as the world's most widely prescribed class of drugs, statins may not be the best option for all patients with elevated low density lipoprotein (LDL) cholesterol levels.

Five things for pharma marketers to know: Thursday, December 29, 2016

Five things for pharma marketers to know: Thursday, December 29, 2016

By

Gilead forms network to encourage access to hep.-C drugs; Dentsu CEO to resign following the suicide of a staffer; BI to divest animal-health products

Five things for pharma marketers to know: Tuesday, December 27, 2016

Five things for pharma marketers to know: Tuesday, December 27, 2016

By

Allergan's board endorses its social contract with patients; drugmakers that market painkillers are hiring DEA officials; the FDA approves new Biogen drug

Opinion

How to Shatter the Glass Ceiling

How Pharma Can Benefit from the Transformation of Pharmacy

Newsletters

Live at MM&M Transforming Healthcare

Pharma faces its 'oh, shit' moment

In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.

Merck, Takeda execs: Is AI the new bad app?

One executive referred to AI as a "black box" and as the "Tower of Babel."

Value-based care requires innovators to challenge the status quo

Execs stressed the importance of collaboration, consumer-mindedness.

Admetsys wins the 2017 MM&M Startup Showdown

The artificial pancreas can provide value to the health system.

Top 40 Healthcare Transformers

MM&M honors 40 upstarts and veteran innovation gurus.

Top 10 Innovation Catalysts

For the first time MM&M honors a group of 10 agency execs.